Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of the Advanced Practitioner in Oncology|June 6, 2022
The Advanced Practice Role in Clinical Trials: Past, Present, and FutureColleen LewisJournal of the Advanced Practitioner in Oncology|February 18, 2021
Precision Oncology Comes of Age: Tumor-Agnostic ApproachesColleen Lewis, R Donald HarveyClinical Journal of Oncology Nursing|May 18, 2019
Immune Checkpoint Inhibitor Therapy: Key Principles When Educating PatientsLaura S Wood, Nancy P Moldawer, Colleen LewisJournal of Innovation in Health Informatics|June 28, 2016
Mining reflective continuing medical education data for family physician learning needsDenice Colleen Lewis, Pierre Pluye, Charo Rodriguez, et al.Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Sleep Health Behind Bars: A Global Scoping Review of Sleep in Carceral SettingsVictoria Hummel, Jerimiah Kouka, Patrick Li, et al.Cancer|February 2, 2012
Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trialsRebecca D Pentz, Margaret White, R Donald Harvey, et al.JCO Oncology Practice|May 20, 2020
Provider Recommendations for Phase I Clinical Trials Within a Shared Decision-Making Model in Phase I Cancer Clinical Trial DiscussionsRachel S Hianik, Gavin P Campbell, Eli Abernethy, et al.Ethics & Human Research|February 26, 2022
Therapeutic Misconception about Research Procedures: Does a Simple Information Chart Improve Understanding?Gavin Campbell, Margie D Dixon, Minisha Lohani, et al.Oncology|June 19, 2018
Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I TrialsTaofeek K Owonikoko, Adeniyi K Busari, Sungjin Kim, et al.Blood Cancer Journal|January 6, 2019
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I StudyJonathan L Kaufman, Roberto Mina, Andrzej J Jakubowiak, et al.Pageof 2